China National Accord Medicines (SZSE:200028) Dividend Payout Ratio: 1.27 (As of Jun. 2026) — 606% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:200028 China National Accord Medicines Corp Ltd SZSE:200028
82 GF Score
Price HK$12.01
GF Value HK$13.65
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is China National Accord Medicines Dividend Payout Ratio?

China National Accord Medicines SZSE:200028 -0.50% 82 Dividend Payout Ratio is 1.27 as of Jun. 2026, which is 606% above its 10-year median of 0.18. GuruFocus rates SZSE:200028 with a GF Score™ of 82/100 and a GF Value™ of HK$13.65 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 65 Medical Distribution companies, China National Accord Medicines ranks better than 69.23% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. China National Accord Medicines's Dividend Payout Ratio for the months ended in Jun. 2026 was 1.27.

The historical rank and industry rank for China National Accord Medicines's Dividend Payout Ratio or its related term are showing as below:

SZSE:200028' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.1   Med: 0.18   Max: 0.65
Current: 0.29

During the past 13 years, the highest Dividend Payout Ratio of China National Accord Medicines was 0.65. The lowest was 0.10. And the median was 0.18.

SZSE:200028's Dividend Payout Ratio is ranked better than
69.23% of 65 companies
in the Medical Distribution industry
Industry Median: 0.45 vs SZSE:200028: 0.29

As of today (2026-09-15), the Dividend Yield % of China National Accord Medicines is 5.85%.

During the past 13 years, the highest Trailing Annual Dividend Yield of China National Accord Medicines was 5.90%. The lowest was 0.39%. And the median was 1.42%.

China National Accord Medicines's Dividends per Share for the months ended in Jun. 2026 was HK$0.71.

During the past 12 months, China National Accord Medicines's average Dividends Per Share Growth Rate was 85.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -7.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -0.90% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 13.80% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of China National Accord Medicines was 97.20% per year. The lowest was -7.40% per year. And the median was 15.40% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

China National Accord Medicines (SZSE:200028) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

China National Accord Medicines Dividend Payout Ratio Related Terms

China National Accord Medicines Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for China National Accord Medicines's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China National Accord Medicines Dividend Payout Ratio Chart

China National Accord Medicines Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.19 0.30 0.67 0.19

China National Accord Medicines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.00 0.00 0.00 1.27

SZSE:200028 vs MCK, COR, CAH: Dividend Payout Ratio Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Accord Medicines Dividend Payout Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Dividend Payout Ratio falls into.


SZSE:200028
82GF Score
China National Accord Medicines Corp Ltd SZSE:200028
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China National Accord Medicines Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

China National Accord Medicines's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.367/ 1.978
=0.19

China National Accord Medicines's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=0.708/ 0.557
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 1.27 mean?
China National Accord Medicines (SZSE:200028) has a Dividend Payout Ratio of 1.27 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China National Accord Medicines and its competitors. This is 606% above median its historical median of 0.18. Over the past decade, China National Accord Medicines' Dividend Payout Ratio has ranged from 0.10 to 0.65. According to the industry distribution chart, China National Accord Medicines ranks #20 out of 65 companies in the Medical Distribution industry, placing it in the top 30.8%.
Is China National Accord Medicines' Dividend Payout Ratio too high?
China National Accord Medicines' current Dividend Payout Ratio of 1.27 is 606% above median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.65. The Medical Distribution industry median Dividend Payout Ratio is 0.45. China National Accord Medicines' value of 1.27 is 182.2% above this industry median. Based on the distribution chart, China National Accord Medicines ranks #20 out of 65 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, China National Accord Medicines has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Accord Medicines' Dividend Payout Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, China National Accord Medicines ranks #20 out of 65 companies for Dividend Payout Ratio. This puts China National Accord Medicines in the upper half of its industry. The industry median Dividend Payout Ratio is 0.45. China National Accord Medicines' value of 1.27 is 182.2% above this benchmark. Historically, China National Accord Medicines' own Dividend Payout Ratio has ranged from 0.10 to 0.65 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.45, China National Accord Medicines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Distribution company?
The median Dividend Payout Ratio among Medical Distribution companies is 0.45, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China National Accord Medicines's current Dividend Payout Ratio of 1.27 is 182.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on China National Accord Medicines and its competitors. For the Medical Distribution industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China National Accord Medicines's current Dividend Payout Ratio is 1.27, which is 606% above median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Accord Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Accord Medicines (SZSE:200028) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$13.65, compared to a current price of HK$12.01 — trading 12% below its estimated fair value. The current Dividend Payout Ratio is 1.27, which is 606% above median its 10-year median of 0.18 and 182.2% above the Medical Distribution industry median of 0.45. China National Accord Medicines' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For China National Accord Medicines (SZSE:200028), the current Dividend Payout Ratio is 1.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China National Accord Medicines (SZSE:200028) Overvalued in 2026?

Based on GuruFocus' analysis, China National Accord Medicines stock appears to be undervalued. The current stock price of HK$12.01 is trading 12% below its estimated GF Value™ of HK$13.65. GuruFocus considers China National Accord Medicines to be Modestly Undervalued.

Key valuation signals for SZSE:200028:

  • Dividend Payout Ratio: 1.27 (606% above median its 10-year median of 0.18)
  • GF Value™: HK$13.65 vs. price of HK$12.01 (12% below fair value)
  • GF Score™: 82/100 with 6 warning signs
  • Industry Position: 182.2% above the Medical Distribution median (#20 of 65)

No single metric tells the full story. See the SZSE:200028 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China National Accord Medicines Business Description

Other Exchanges 000028:China
Address No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
82GF Score

Get the complete analysis for SZSE:200028

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.01
Price
HK$13.65
GF Value